Author

T. Cantz

h-index 1 View on Semantic Scholar

We have 2 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#gene editing Case report Open access Nov 2026

Liver biopsy confirms precise and efficient correction of SERPINA1 after in vivo Base Editing in a Patient with Alpha-1 Antitrypsin Deficiency.

Sustained biologically active AAT levels support feasibility and potential of this approach for the treatment of AATD, and substantial and precise hepatic correction of the pathogenic SERPINA1 PI*ZZ variant is achieved.

S. Krooss, Tai-Hua Yang, Q. Yuan et al. · Journal of Hepatology · 0 citations

Editorial Open access Jul 2026

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach

The main goal of the German National Strategy for GCT is to ensure patient access to advanced therapies while strengthening Germany’s position as an international hub for biomedical innovation.

Christian Gallus, F. Ayuk, P. Beckhove et al. · Human Gene Therapy · 0 citations